Wheezing Clinical Trial
— NiNbIOfficial title:
Non-invasive Differential Diagnosis of Noisy Breathing Infants and Toddlers Based on Biomarker Profiles in Exhaled Breath and Nasal Mucus and Based on Breath Sound Analysis
NCT number | NCT04128592 |
Other study ID # | NiNbI-001 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | October 30, 2018 |
Est. completion date | May 2020 |
Almost 50% of all children have at least 1 episode of noisy breathing before the age of 2 years and almost 25% of these children have more episodes of noisy breathing. The lack of an objective technique for diagnosing noisy breathing children often leads to overrated diagnosis of "wheezing", whereas there may be other noisy breathing phenotypes, like "rattling", that don't favor from the same therapeutic treatment. Presumably, different underlying pathophysiological mechanisms are involved with different biomarker profiles characteristic for different phenotypes. The goal of this study is to optimize the diagnosis of noisy breathing infants and toddlers. Children will be followed for a treatment period of 6 weeks and will visit the paediatrician 3 times (week 0, 3 and 6). During the consultations breath sound analysis will be performed and a breath sample and a nasal mucus will be collected to analyse biomarker profiles. Both methods for diagnosing noisy breathing infants are non-invasive and will be compared to the standard procedure of the paediatrician which consists of auscultation and palpation of the chest. An objective and non-invasive method for diagnosing noisy breathing infants and toddler will pave the way for more cost-effective and personalized prescription of therapies which will increase the quality of life of children with noisy breathing.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | May 2020 |
Est. primary completion date | March 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 2 Months to 18 Months |
Eligibility |
Inclusion Criteria: - clinical diagnosis of noisy breathing ("wheezing" or "rattling") Exclusion Criteria: - born before pregnancy week 37 - congenital or genetic conditions (Down syndrome, Klinefelter's syndrome, …) - acquired chronic respiratory diseases (bronchopulmonary dysplasy, lung fibrosis, …) |
Country | Name | City | State |
---|---|---|---|
Belgium | Jessa Ziekenhuis | Hasselt |
Lead Sponsor | Collaborator |
---|---|
Hasselt University | Jessa Hospital, VITO |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation | Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration. | week 0 | |
Primary | Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation | Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.which differentiate "wheezing" and "rattling" infants and toddlers. Comparing diagnosis based on these biomarker profiles to the diagnosis made by the pediatrician based on auscultation and palpation. | week 3 | |
Primary | Noisy breathing diagnosis made by pediatrician based on anamnesis and auscultation | Noisy breathing diagnosis is made by the same pediatrician and is based on intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or of continuous duration.which differentiate "wheezing" and "rattling" infants and toddlers. Comparing diagnosis based on these biomarker profiles to the diagnosis made by the pediatrician based on auscultation and palpation. | Week 6 | |
Primary | exhaled breath volatiles | exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS) | week 0 | |
Primary | exhaled breath volatiles | exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS) | week 3 | |
Primary | exhaled breath volatiles | exhaled breath volatiles analyzed with Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) and Gas Chromatography Mass Spectrometry (GC-MS) | week 6 | |
Primary | respiratory pathogens | respiratory pathogens present in a nasopharyngeal swab detected using PCR | week 0 | |
Primary | respiratory pathogens | respiratory pathogens present in a nasopharyngeal swab detected using PCR | week 3 | |
Primary | respiratory pathogens | respiratory pathogens present in a nasopharyngeal swab detected using PCR | week 6 | |
Primary | level of inflammation markers | level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay | week 0 | |
Primary | level of inflammation markers | level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay | week 3 | |
Primary | level of inflammation markers | level of inflammation markers in the nasopharyngeal swab using multiplex immune-assay | week 6 | |
Secondary | Breath sound recordings evaluated by expert panel of pediatricians | Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording. | week 0 | |
Secondary | Breath sound recordings evaluated by expert panel of pediatricians | Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording. | week 3 | |
Secondary | Breath sound recordings evaluated by expert panel of pediatricians | Intensity and duration of both wheeze and rattle are scored on a scale of 0 to 10, whit 0 indicating not present and 10 indicating very high intensity or continuous over the recording. | week 6 | |
Secondary | Treatment response assessed by online journal for parents | Parents are asked what type of noisy breathing symptoms their child had during the day. Options are: (1) Wheezing; (2) Rattling; (3) Both, but mostly wheezing; (4) Both, but mostly rattling; (5) Both in equal amounts, (6) No noisy breathing today. In the online questionnaire sound fragments of wheezing and rattling are available incase parents are in doubt. | week 6 | |
Secondary | Recurrence of symptoms assessed by follow up questionnaire | Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online | 3 months after week 6 | |
Secondary | Recurrence of symptoms assessed by follow up questionnaire | Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online | 6 months after week 6 | |
Secondary | Recurrence of symptoms assessed by follow up questionnaire | Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online | 9 months after week 6 | |
Secondary | Recurrence of symptoms assessed by follow up questionnaire | Online questionnaire asks about noisy breathing symptoms in the past 3 months, their frequency and seriousness. In the online | 12 months after week 6 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04669288 -
AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department
|
Phase 3 | |
Withdrawn |
NCT04584034 -
Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial
|
Phase 4 | |
Terminated |
NCT02269761 -
Chest Ultrasound of ER Patients With Cough or SOB
|
||
Enrolling by invitation |
NCT00775697 -
Montelukast in Children With Wheezing
|
Phase 4 | |
Completed |
NCT00749528 -
Evaluation of Toxic Metals, Trace Elements and Total Antioxidant Activity in Children With Recurrent Wheezing
|
N/A | |
Recruiting |
NCT00494624 -
Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children
|
Phase 4 | |
Recruiting |
NCT06093152 -
Video Assisted Study of Salbutamol Response in Viral Wheezing
|
||
Completed |
NCT01452945 -
Bedside Lung Ultrasound in Young Children Presenting to the Emergency Department (ED) With Wheezing
|
N/A | |
Withdrawn |
NCT00628303 -
A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants
|
Phase 3 | |
Completed |
NCT01028560 -
Allergy Immunotherapy for the Reduction of Asthma
|
Phase 1/Phase 2 | |
Completed |
NCT00626808 -
A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children
|
Phase 4 | |
Completed |
NCT00507676 -
Lung Function and Structure in Healthy Infants and Infants With Recurrent Wheezing
|
N/A | |
Completed |
NCT03600428 -
Safety of LAIV4 in Children With Asthma
|
Phase 4 | |
Recruiting |
NCT06106646 -
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
|
||
Recruiting |
NCT05710081 -
Bacterial Lysate In Preventing Asthma
|
Phase 3 | |
Completed |
NCT04011709 -
A Methodology Trial Using the VR647 Inhalation System in Pediatric Subjects Who Have Previously Received Inhaled Therapy
|
Early Phase 1 | |
Active, not recruiting |
NCT03377192 -
Impedance Pneumography in Assessment of Asthma Control in Preschool Children
|
||
Completed |
NCT01142505 -
Wheeze and Intermittent Treatment
|
Phase 3 | |
Active, not recruiting |
NCT04942483 -
Using Specific Tests in Preschool Children With Wheeze to Help us Determine the Necessity of Inhaled Corticosteroid Therapy (Feasibility Study).
|
||
Recruiting |
NCT05684848 -
Evaluate the Effect of Nasal Spray in the Prevention of RTI in Children With Pre-school Wheezing
|
N/A |